Supplementary Tables S1-S7 from Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer

Supplementary Tables S1-S7. This is a multi-"tabbed" Excel file containing the supplementary data of the manuscript and includes a "Summary" tab with descriptions/captions for the enclosed data sheets. They are as follows: Supplementary Table S1: 800-gene Ovarian Cancer Biomarker Nanostring Panel content Supplementary Table S2: Fourteen differentially expressed genes between Plat-R primary vs Plat-S primary tumors (discovery dataset) Supplementary Table S3: Sixty five differentially expressed genes between Plat-R recurrent vs Plat-R primary tumors (discovery dataset) Supplementary Table S4: TP53 mutation status in 32 Plat-R and 26 Plat-S primary tumors (discovery dataset) Supplementary Table S5: CNV analysis on 35 cancer genes in 32 Plat-R and 26 Plat-S primary tumors (discovery dataset) Supplementary Table S6: Demographics summary of ICON7 chemo-treatment arm (biomarker population vs. ITT) Supplementary Table S7: Ten differentially expressed genes between Plat-R primary vs Plat-S primary tumors (ICON7 dataset)

补充表S1~S7。本文件为多工作表格式的Excel文件，收录本论文的补充数据，其中包含一个名为"Summary（摘要）"的工作表，用于对各附属数据表的内容与标注进行说明。各补充表详情如下：
补充表S1：800基因卵巢癌生物标志物纳米串（Nanostring）检测面板的内容
补充表S2：铂耐药（Plat-R）原发肿瘤与铂敏感（Plat-S）原发肿瘤之间的14个差异表达基因（发现数据集）
补充表S3：铂耐药复发肿瘤与铂耐药原发肿瘤之间的65个差异表达基因（发现数据集）
补充表S4：32例铂耐药原发肿瘤与26例铂敏感原发肿瘤的TP53突变状态（发现数据集）
补充表S5：针对32例铂耐药原发肿瘤与26例铂敏感原发肿瘤中的35个癌症基因的拷贝数变异（CNV，Copy Number Variation）分析（发现数据集）
补充表S6：ICON7化疗组的人口统计学特征汇总（生物标志物队列 vs 意向治疗（ITT，Intent-to-Treat）队列）
补充表S7：ICON7数据集中铂耐药原发肿瘤与铂敏感原发肿瘤之间的10个差异表达基因